Liquidia Technologies (LQDA) Competitors $12.78 +0.33 (+2.65%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$12.71 -0.07 (-0.56%) As of 07/8/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LQDA vs. TMDX, BLCO, SLNO, INSP, NVST, PRCT, LIVN, WRBY, NVCR, and LMATShould you be buying Liquidia Technologies stock or one of its competitors? The main competitors of Liquidia Technologies include TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Liquidia Technologies vs. Its Competitors TransMedics Group Bausch + Lomb Soleno Therapeutics Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova Warby Parker NovoCure LeMaitre Vascular TransMedics Group (NASDAQ:TMDX) and Liquidia Technologies (NASDAQ:LQDA) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk. Which has higher valuation and earnings, TMDX or LQDA? TransMedics Group has higher revenue and earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTransMedics Group$441.54M9.55$35.46M$1.3691.71Liquidia Technologies$14M78.04-$130.39M-$1.58-8.09 Does the media favor TMDX or LQDA? In the previous week, TransMedics Group had 4 more articles in the media than Liquidia Technologies. MarketBeat recorded 8 mentions for TransMedics Group and 4 mentions for Liquidia Technologies. TransMedics Group's average media sentiment score of 0.85 beat Liquidia Technologies' score of 0.31 indicating that TransMedics Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Liquidia Technologies 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is TMDX or LQDA more profitable? TransMedics Group has a net margin of 10.03% compared to Liquidia Technologies' net margin of -903.80%. TransMedics Group's return on equity of 21.88% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets TransMedics Group10.03% 21.88% 6.15% Liquidia Technologies -903.80%-177.91%-60.15% Do analysts rate TMDX or LQDA? TransMedics Group currently has a consensus target price of $127.33, indicating a potential upside of 2.09%. Liquidia Technologies has a consensus target price of $26.89, indicating a potential upside of 110.40%. Given Liquidia Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Liquidia Technologies is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransMedics Group 0 Sell rating(s) 3 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.80Liquidia Technologies 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in TMDX or LQDA? 99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 64.5% of Liquidia Technologies shares are held by institutional investors. 7.0% of TransMedics Group shares are held by company insiders. Comparatively, 30.1% of Liquidia Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, TMDX or LQDA? TransMedics Group has a beta of 2.06, meaning that its share price is 106% more volatile than the S&P 500. Comparatively, Liquidia Technologies has a beta of -0.01, meaning that its share price is 101% less volatile than the S&P 500. SummaryTransMedics Group beats Liquidia Technologies on 11 of the 16 factors compared between the two stocks. Get Liquidia Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LQDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidia TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.06B$2.88B$5.47B$8.95BDividend YieldN/A2.46%5.25%4.06%P/E Ratio-8.0920.8027.0020.10Price / Sales78.04286.98435.75120.29Price / CashN/A41.1936.8257.86Price / Book14.047.487.985.56Net Income-$130.39M-$55.04M$3.16B$248.40M7 Day Performance5.97%5.44%3.69%6.04%1 Month Performance-29.08%2.38%2.91%7.69%1 Year Performance1.19%5.53%34.30%20.97% Liquidia Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia Technologies3.182 of 5 stars$12.78+2.7%$26.89+110.4%+2.7%$1.06B$14M-8.0950High Trading VolumeTMDXTransMedics Group1.5222 of 5 stars$134.01+1.9%$127.33-5.0%-16.4%$4.45B$441.54M98.54210BLCOBausch + Lomb3.1036 of 5 stars$13.03+5.1%$15.54+19.3%-8.2%$4.39B$4.79B-12.6513,500Analyst ForecastHigh Trading VolumeSLNOSoleno Therapeutics4.7235 of 5 stars$83.78+0.6%$107.10+27.8%+101.0%$4.20BN/A-18.1330INSPInspire Medical Systems4.8272 of 5 stars$129.28-2.4%$211.91+63.9%-1.7%$3.91B$802.80M59.581,246News CoveragePositive NewsNVSTEnvista3.8065 of 5 stars$19.58-0.5%$20.23+3.3%+22.8%$3.33B$2.51B-3.0012,300PRCTPROCEPT BioRobotics2.6605 of 5 stars$57.60+1.2%$90.00+56.3%-9.8%$3.15B$224.50M-33.88430News CoverageAnalyst ForecastLIVNLivaNova3.2024 of 5 stars$45.02-1.6%$59.29+31.7%-9.6%$2.49B$1.25B-11.012,900Positive NewsWRBYWarby Parker1.9504 of 5 stars$21.94+0.2%$22.88+4.3%+45.0%$2.29B$771.32M-182.833,780NVCRNovoCure3.5767 of 5 stars$17.80-1.1%$32.83+84.5%+9.4%$2.01B$605.22M-11.791,488Analyst ForecastLMATLeMaitre Vascular1.884 of 5 stars$83.05+0.6%$97.83+17.8%+1.3%$1.87B$219.86M41.94490 Related Companies and Tools Related Companies TransMedics Group Competitors Bausch + Lomb Competitors Soleno Therapeutics Competitors Inspire Medical Systems Competitors Envista Competitors PROCEPT BioRobotics Competitors LivaNova Competitors Warby Parker Competitors NovoCure Competitors LeMaitre Vascular Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LQDA) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.